Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Valerie Shavell

Obstetrics & Gynecology Grand Rapids, MI Medical Doctor

NPI 1427252667 CMS profile 109846

3230 Eagle Park Dr Ne, Suite 100, Grand Rapids, MI 49525

Open in the dashboard

General payments

$1,975

98 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Valerie Shavell of Grand Rapids, MI is reported in the CMS Open Payments database as having received $1,975 across 98 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $116 5
2024 General $234 9
2023 General $489 21
2022 General $361 16
2021 General $284 19
2020 General $165 9
2019 General $326 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Valerie Shavell
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Valerie Shavell were reported at $116. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Valerie Shavell Obstetrics & Gynecology median Middle half National median
2019 $326 $172 $62–$391 $163
2020 $165 $94 $36–$222 $114
2021 $284 $136 $42–$369 $132
2022 $361 $160 $50–$433 $149
2023 $489 $169 $56–$423 $160
2024 $234 $152 $50–$371 $164
2025 $116 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sumitomo Pharma America, Inc. $425 16 payments
  2. EMD Serono, Inc. $339 16 payments
  3. Hologic, LLC $300 25 payments
  4. Ferring Pharmaceuticals Inc. $296 13 payments
  5. AbbVie, Inc. $283 13 payments
  6. CooperSurgical, Inc. $106 5 payments
  7. Myovant Sciences Inc. $78 3 payments
  8. Myovant Sciences GmbH $49 1 payment
  9. Pfizer Inc. $30 2 payments
  10. Organon LLC $23 1 payment
  11. Other $45 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,975 98 payments
Products named General payments · program years 2019–2025
  1. MYFEMBREE Hormone Therapy $475 17 payments
  2. ORILISSA Womens Health $215 10 payments
  3. MENOPUR Reproductive Health $177 8 payments
  4. MYOSURE TISSUE REMOVAL DEVICE Surgical $136 14 payments
  5. Gonal-f $97 6 payments
  6. MENOPUR Reproductive Health $87 3 payments
  7. MYOSURE TISSUE REMOVAL DEVICE Surgical $82 5 payments
  8. MYFEMBREE Womens Health $77 3 payments
  9. Orilissa Endocrinology $68 3 payments
  10. ORIAHNN $67 3 payments
  11. Other $453 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record